Fosamax Lawsuit Update: New Study Finds Patients Taking Bisphosphonates Face Increased Risk of Cance

Bernstein Liebhard LLP continues to investigate Fosamax lawsuits on behalf of individuals who suffered atypical femur fractures allegedly due to their use of Fosamax. New York, NY (PRWEB) December 01, 2012 As Fosamax lawsuits continue to move forward, a new study has found that patients who take bisphosphonates like Fosamax may be at increased risk for upper gastrointestinal cancer, Bernstein Liebhard LLP reports. The study compared 8,636 men and women who had a recorded incident of upper gastrointestinal cancer, matched to 34,544 controls with no record of disease. Bisphosphonate use was
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories